Manulife (Manufacturers Life Insurance)
JUNO

Manulife (Manufacturers Life Insurance)’s Juno Therapeutics, Inc. JUNO Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,173
Closed -$145K – 4436
2017
Q4 		$145K Sell
3,173
-120
-4% -$5.99K ﹤0.01% 3253
2017
Q3 		$148K Sell
3,293
-112
-3% -$3.82K ﹤0.01% 3202
2017
Q2 		$102K Buy
3,405
+228
+7% +$5.63K ﹤0.01% 3355
2017
Q1 		$70K Hold
3,177
– – ﹤0.01% 3284
2016
Q4 		$60K Buy
3,177
+200
+7% +$4.89K ﹤0.01% 3379
2016
Q3 		$89K Sell
2,977
-267,855
-99% -$8.33M ﹤0.01% 3254
2016
Q2 		$10.4M Sell
270,832
-23
-0% -$955 0.02% 674
2016
Q1 		$10M Buy
270,855
+204
+0.1% +$7.11K 0.01% 674
2015
Q4 		$11.9K Hold
270,651
– – 0.01% 603
2015
Q3 		$11K Sell
270,651
-24
-0% -$1.05K 0.01% 626
2015
Q2 		$14.4K Buy
+270,675
New +$14.4M 0.02% 527

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Manulife (Manufacturers Life Insurance)'s JUNO Position: Q1 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 3,173 shares — an estimated $145K sold.

Manulife (Manufacturers Life Insurance) first reported a position in JUNO in Q2 2015 and held it in 11 quarters. The position peaked at $10.4M in Q2 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 3,173 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $145K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 11 quarters.
  • Manulife (Manufacturers Life Insurance)'s Juno Therapeutics, Inc. position peaked at $10.4M in Q2 2016.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2018, filed 15 May 2018.